CDK7 and acute lymphoblastic leukemia: To test the hypothesis that pharmacological inhibition of CDK7 leads to broader chromatin organization changes in T-ALL, we systematically assessed the relative contribution of trans-acting factors and found that CDK7 was ranked among the top factors in regulating chromatin organization, whereas the predicted contribution of NOTCH1 was ranked much lower (Fig. 6h,i).